Borosil Scientific Ltd
Borosil Scientific Ltd Q1 FY27 Results & Presentation Highlights: Revenue ₹106.8 Cr, PAT ₹4.4 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Borosil Scientific Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).
From Borosil Scientific Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr)
- Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr)
- EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: ₹5.8 Cr)
- EBITDA (Standalone): ₹11.5 Cr, up 15.3% YoY (Q1FY26: ₹9.9 Cr)
- Category-wise Q1FY27 sales growth YoY:
- Lab Consumables: ₹45.8 Cr, flat (-0.1%)
- Lab Equipment: ₹12.3 Cr, +31.4%
- Process System: ₹8.5 Cr, +8.6%
- Pharma Packaging: ₹23.1 Cr, +31.6%
- Domestic Glassware: ₹15.3 Cr, +4.0%
- Others: ₹1.7 Cr, +175.6%
2 more points management made on revenue & sales performance
Profitability & Margins
See what Borosil Scientific Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Borosil Scientific Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Borosil Scientific Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹143 Cr, net profit ₹27 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Borosil Scientific Ltd's management said in earlier quarters
Others in Industrial Products this season
- Graphite India Ltd (Q1 FY27)
842 Crores, up 26.6% year-on-year (YoY) . Key investor presentation takeaways from Graphite India Ltd's Q1 FY27 investor presentation — and how it ranks against
- Bansal Wire Industries Ltd (Q1 FY27)
Continued expansion in B2C segments like farming, poultry, and fencing wires, which already contribute about 10% of revenue. Key concall takeaways from Bansal…
- Welspun Specialty Solutions Ltd (Q1 FY27)
. Key concall takeaways from Welspun Specialty Solutions Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Technocrats Plasma Systems Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹13,130.9 lakhs, up 166.0% YoY from ₹4,935.7 lakhs in FY25 (Page 28). Key investor presentation takeaways from Technocrats Pla
Frequently Asked Questions
What were Borosil Scientific Ltd Q1 FY27 results?
Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).
What is Borosil Scientific Ltd share price analysis?
Borosil Scientific Ltd currently shows a neutral. The stock trades at a P/E of 23.9 with a market cap of ₹1,064 Cr. Investors should review the full earnings analysis for detailed insights.
Is Borosil Scientific Ltd planning capital expenditure?
The presentation does not explicitly provide specific details on capital expenditure (capex) amounts, capacity expansion figures, or new plants/projects with timelines or current status.
Keep Borosil Scientific Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.